Bio Innovation Conference | 2019 Speakers
page-template,page-template-all-speakers,page-template-all-speakers-php,page,page-id-17376,page-parent,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive

2019 Speakers

Brian Abraham- Director Market Access & Revenue Management, BDO
Henry Ahn- SBIR/STTR Program Director, National Science Foundation
Julia Barrett, MD, MPH- Senior Clinical Consultant, Biologics Consulting
Subhendu Basu Ph.D.- Chief Operating Officer, Adaptive Phage Therapeutics
Diana Bernstein, Ph.D.- Senior Associate, MRL Ventures
Pete Buzy- President, Paragon Gene Therapy, Catalent Biologics
Judy Costello- Managing Director, Economic Development, BioHealth Innovation
Doug Doerfler- President and Chief Executive Officer, MaxCyte
Michael Druckman- Partner, Washington, D.C., Hogan Lovells
Marc Elrich- Montgomery County Executive
Emily English, Ph.D.- Chief Executive Officer, Gemstone Therapeutics
David Feigal, M.D., MPH- Partner, NDA Partners
Shiva Fritsch- Senior Vice President of Human Resources, Regenxbio
Brian Gaines- Chief Executive Officer, Learning Undefeated
Jeff Galvin- Founder and Chief Executive Officer, American Gene Technologies
Luis Gutierrez- Past President, Commercialization Services, Covance
Jeffrey Hung, Ph.D.- Chief Commercial Officer, Vigene Biosciences
Murat Kalayoglu, M.D., Ph.D., MBA- President & CEO, Cartesian Therapeutics, Inc.
Robert Lindblad, M.D.- Chief Medical Officer, Emmes
Michelle McMurry-Heath, M.D., Ph.D.- Vice President, External Innovation, Global Leader for Regulatory Science, and Executive Director of Scientific Partnerships, JLABS @ Washington, DC
Christopher McDonald- Vice President of Manufacturing, Kite Pharma
Joseph Naft- Director, Maryland Industrial Partnerships (MIPS) Program
Kimberly Noonan, Ph.D.- Founder, Executive Vice President and Chief Scientific Officer, WindMIL Therapeutics
Ram Palanki, Pharm.D.- Senior Vice President of Commercial Strategy and Operations, REGENXBIO
Nicole Palya Wood- Senior Director of State Advocacy, PhRMA
Randy Prebula- Partner, Washington, D.C., Hogan Lovells
Tyrell Rivers, Ph.D.- Executive Director of Corporate Development, AstraZeneca
Martin Rosendale- Chief Executive Officer, Maryland Life Sciences
Jon Rowley, Ph.D.- Founder and Chief Product Officer, RoosterBio
William Rust, Ph.D.- Chief Executive Officer and Co-Founder, Seraxis
Joseph Sanchez, Ph.D.- Associate Director of Learning & Talent Development, AstraZeneca Biologics
Kelly Schulz- Secretary, Maryland Department of Commerce
Lyndsey Scull- Vice President, Communications, Alliance for Regenerative Medicine
Linda Segal- Principal, The McCormick Group
Sarah Sheppard- Director, Education and Workforce, Maryland Department of Commerce
Paul Silber- Founding Principal, Blu Venture Investors
Brad L. Stewart- Chief Executive Officer, Immunology Partners
John Tisdale, M.D.- Chief, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health
Aaron Vernon- Vice President, Engineering and Supply Chain, Autolus
R. Jacob Vogelstein, Ph.D.- General Partner, Camden Partners
John Walker- Manufacturers Extension Partnership Liaison, NIIMBL
Steven Walker- Chief Business Officer and Commercial Strategist, Biologics Consulting